Merck & Co. swings to Q4 profit on lower charges
Merck & Co. swung to a fourth-quarter profit because of lower restructuring and other charges and higher sales of most of its key drugs. Full story
Facebook apologizes for Merck mix-up
Facebook said on Monday that it made a mistake in letting Merck & Co take over a page on the social networking website from its German rival Merck KGaA. The takeover had prompted an unusual Nov. 21 filing by Merck KGaA with a New York state court. In it, Merck KGaA sought to force Facebook to explai Full story
Reuters: Merck to pay nearly $1 bln to settle U.S. charges
Nov 22 (Reuters) - Merck & Co will pay roughly $950million to settle criminal and civil charges that it promotedthe painkiller drug Vioxx for an unapproved use, the U.S.Justice Department said on Tuesday. Full story
Reuters: US advisers back Vytorin in some kidney patients
SILVER SPRING, Md., Nov 2 (Reuters) - U.S. health adviserson Wednesday put some weight behind Merck & Co's cholesterol-lowering drug Vytorin in preventing stroke andother heart problems in patients with chronic kidney disease. Full story
FDA expands approval of shingles vaccine
The Food and Drug Administration has approved a shingles vaccine from Merck for patients between the ages of 50 and 59. Full story
Black holes 'belching next meals into oblivion'
Supermassive black holes are a bit like the Cookie Monster, gobbling up grub so greedily that they fling away huge amounts of perfectly good "food," a new study suggests. Full story
Sponsored Links
advertisement | ad info
Related Photos
A view of the Merck & Co. campus in Linden, New Jersey
A view of the Merck & Co. campus in Linden, New Jersey March 9, 2009. REUTERS/Jeff Zelevansky
